Sunesis Pharmaceuticals (SNSS) Misses Q1 EPS by 12c
Get Alerts SNSS Hot Sheet
Price: $5.32 --0%
Financial Fact:
Other income (expense), net: 23K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Other income (expense), net: 23K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Sunesis Pharmaceuticals (NASDAQ: SNSS) reported Q1 EPS of ($0.30), $0.12 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $0 versus the consensus estimate of $90 thousand.
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
For earnings history and earnings-related data on Sunesis Pharmaceuticals (SNSS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Arca Biopharma (ABIO) Reports Q1 Loss of $0.14
- COPT Defense Properties (CDP) Reports In-Line Q1 EPS; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!